ARGS - Argos Therapeutics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow

Income Statement

Annual
All numbers in thousands
Revenue12/31/201612/31/201512/31/2014
Total Revenue945.468518.3291,974.019
Cost of Revenue---
Gross Profit945.468518.3291,974.019
Operating Expenses
Research Development38,307.23662,054.82345,498.916
Selling General and Administrative14,203.30111,011.0118,599.359
Non Recurring741.114741.114741.114
Others---
Total Operating Expenses---
Operating Income or Loss-52,306.183-72,547.505-52,124.256
Income from Continuing Operations
Total Other Income/Expenses Net1,052.81322.583-58.103
Earnings Before Interest and Taxes-51,253.37-72,524.922-52,182.359
Interest Expense1,774.742,263.5991,123.579
Income Before Tax-53,028.11-74,788.521-53,305.938
Income Tax Expense---
Minority Interest---
Net Income From Continuing Ops-53,028.11-74,788.521-53,305.938
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-53,028.11-74,788.521-53,305.938
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-53,028.11-74,788.521-54,169.164